{
    "title": "Concerns grow for pharmaceutical giant which could face pressure as drug patents expire",
    "url": "https://www.dailymail.co.uk/money/midasextra/article-2131641/Concerns-grow-pharmaceutical-giant-face-pressure-drug-patents-expire.html",
    "date": "2012-04-18",
    "keywords": [
        "stock",
        "yesterday",
        "market",
        "company",
        "level",
        "price",
        "stop",
        "astrazeneca",
        "pressure",
        "brennan",
        "share",
        "writer",
        "darling",
        "giant",
        "azn",
        "competition",
        "room",
        "profitsthe",
        "war",
        "chest",
        "research",
        "astra",
        "pipeline",
        "acquisition",
        "extent",
        "bid",
        "contribution",
        "cash",
        "disposal",
        "tap",
        "discounting",
        "capital",
        "top",
        "board",
        "david",
        "ceo",
        "shortterm",
        "job",
        "inaction",
        "status",
        "quo",
        "boardroom",
        "yield",
        "cent",
        "ratio",
        "prospect",
        "capitaldebt",
        "takeover",
        "trade",
        "sidewaysresistance",
        "circa",
        "poly",
        "pog",
        "take",
        "profitsrio",
        "rio",
        "resistance",
        "clln",
        "sit",
        "tight",
        "pursuit",
        "positionhomeserve",
        "hsv",
        "isys",
        "material",
        "report",
        "sharescope",
        "dow"
    ],
    "category": [
        "money",
        "midasextra"
    ]
}